| 68a5ee5f-0352-b3ae-3321-c0a22947a31d | 100 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] | SBD | 11 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20210215 |
| 68a5ee5f-0352-b3ae-3321-c0a22947a31d | panzyga 10 % in 100 ML Injection | PSN | 11 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20210215 |
| 68a5ee5f-0352-b3ae-3321-c0a22947a31d | 100 ML Panzyga 100 MG/ML Injection | SY | 11 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20210215 |
| 68a5ee5f-0352-b3ae-3321-c0a22947a31d | Panzyga 10 % per 100 ML Injection | SY | 11 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20210215 |
| e2cc5ddf-119e-ade3-79c2-c712cfbee099 | panzyga 10 % in 100 ML Injection | PSN | 10 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20250508 |
| e2cc5ddf-119e-ade3-79c2-c712cfbee099 | 100 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] | SBD | 10 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20250508 |
| e2cc5ddf-119e-ade3-79c2-c712cfbee099 | Panzyga 10 % per 100 ML Injection | SY | 10 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20250508 |
| e2cc5ddf-119e-ade3-79c2-c712cfbee099 | 100 ML Panzyga 100 MG/ML Injection | SY | 10 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20250508 |
| 9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e0 | Panzyga 10 % per 100 ML Injection | SY | 2 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20250508 |
| 9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e0 | panzyga 10 % in 100 ML Injection | PSN | 2 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20250508 |
| 9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e0 | 100 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga] | SBD | 2 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20250508 |
| 9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e0 | 100 ML Panzyga 100 MG/ML Injection | SY | 2 | These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018 | 20250508 |